Lanreotide
|
|
|
- CAS-Nr.
- 108736-35-2
- Englisch Name:
- Lanreotide
- Synonyma:
- IPSTYL;AUTOGEL;DC-13-116;BIM-23014;LANREOTIDE;bim-23014c;Somatuline;ANGIOPEPTIN;LaroMustine;Lanreotide USP/EP/BP
- CBNumber:
- CB6190280
- Summenformel:
- C54H69N11O10S2
- Molgewicht:
- 1096.32
- MOL-Datei:
- 108736-35-2.mol
|
Lanreotide Eigenschaften
- Siedepunkt:
- 1508.2±65.0 °C(Predicted)
- Dichte
- 1.40±0.1 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Sealed in dry,Store in freezer, under -20°C
- pka
- 9.90±0.15(Predicted)
- Sequenz
- D-2-Nal-[Cys-Tyr-D-Trp-Lys-Val-Cys]-Thr-NH2
- InChIKey
- PUDHBTGHUJUUFI-VHAAONQQNA-N
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| WGK Germany |
3 |
|
|
| HS Code |
3504009000 |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H361 |
Kann vermutlich die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. |
Reproduktionstoxizit?t |
Kategorie 2 |
Warnung |
|
P201, P202, P281, P308+P313, P405,P501 |
|
| Sicherheit |
| P201 |
Vor Gebrauch besondere Anweisungen einholen. |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
| P308+P313 |
BEI Exposition oder falls betroffen: ?rztlichen Rat einholen/?rztliche Hilfe hinzuziehen. |
|
Lanreotide Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Lanreotide is a synthetic octapeptide analogue of somatostatin with enhanced metabolic stability compared with somatostatin. It binds with high affinity to and stimulates the somatostatin receptors SSTR2 and SSTR5, with relatively greater potency at SSTR2 and very low binding to SSTR1, SSTR3 and SSTR4. It is used to treat acromegaly and neuroendocrine tumors.
Chemische Eigenschaften
White to off-white lyophilised powder
Verwenden
Antineoplas tic.
Lanreotide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Lanreotide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 220)Lieferanten
108736-35-2()Verwandte Suche:
- LANREOTIDE
- AUTOGEL
- BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE
- BIM-23014
- ANGIOPEPTIN
- H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2
- H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2, (DISULFIDE BOND)
- IPSTYL
- DC-13-116
- (D-2-NAL5,CYS6,11,TYR7,D-TRP8,VAL10)-SOMATOSTATIN (5-12) AMIDE
- B-NAPHTHYL-D-ALA-CYS-TYR-D-TRP*LYS-VAL-C YS-THR AMID
- bim-23014c
- β-(2-naphthyl)-d-ala-cys-tyr-d-trp-lys-val-cys-thr amide [disulfide bridge: 2-7]
- L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7) disulfide, TFA salt
- 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-7)-disulfide
- 3-(2-Naphtyl)-D-Ala-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys(1)-L-Thr-NH2
- D-βNal-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys(1)-L-Thr-NH2
- Somatuline
- DC-13-116, Angiopeptin, (D-2-Nal5,Cys6'11,Tyr7,D-Trp8,Val10)-SoMatostatin (5-12) aMide, BIM-23014, (D-2-Nal5,Cys6·11,Tyr7,D-Trp8,Val10)-SoMatostatin (5-12) aMide
- Lanreotide, Angiopeptin
- B-naphthyl-D-ala-cys-tyr-D-trp*lys-val-cys-thr am
- LaroMustine
- Lanreotide?Acetate impurity
- Lanreotide USP/EP/BP
- (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- Lanreotide D8Q: What is
Lanreotide D8 Q: What is the CAS Number of
Lanreotide D8 Q: What is the storage condition of
Lanreotide D8 Q: What are the applications of
Lanreotide D8
- TIANFUCHEM---108736-35-2---Lanreotide
- Lanreotide Acetate(net)
- L-Threoninamide,3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-,cyclic (2®
- (4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- T4 40mcg, 100 tablets
- *Tributyl Acetylcitrate Impurity 7
- Lanreotide Angiopeptin acetate
- Lanreotide Ditrifluoroacetate
- Lanreotide, Somatostatin receptor analog
- 108736-35-2
- Peptides
- Somatostatins
- Amino Acids and Peptides
- Biochemicals and Reagents
- BioChemical
- hormones
